👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

Peloton, Oracle and Tesla Rise Premarket

Published 09/11/2020, 08:00 AM
Updated 09/11/2020, 08:01 AM
© Reuters.
BA
-
EBAY
-
DIS
-
JPM
-
ORCL
-
CSGN
-
TSLA
-
DPZ
-
STSA
-
PTON
-

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Friday, September 11th. Please refresh for updates.

  • Peloton (NASDAQ:PTON) stock rose 12% after the exercise bike maker soared past expectations with its quarterly results. JPMorgan (NYSE:JPM) is among a number of investment houses that have lifted price targets after the results.

  • Oracle (NYSE:ORCL) stock rose 4% after the tech giant beat expectations with its first-quarter results as remote work spurred demand for cloud services as well as traditional licensing business.

  • Boeing (NYSE:BA) stock rose 0.8% after the aircraft maker said it was in discussions with U.S. safety regulators about a manufacturing issue found last year in its 787 Dreamliner.

  • Tesla (NASDAQ:TSLA) stock rose 3.6%, continuing its turbulent run. UBS doubled its price target to $325 from $160 ahead of electric car manufacturer’s Sept. 22 battery day. The automaker also plans to export China-made Model 3 cars to Asian and European market, according to reports.

  • Walt Disney (NYSE:DIS) stock rose 0.7% after CFO Christine McCarthy stated that the entertainment giant expects to have reopened "a little over 50%" of its hotels and resorts by the end of the fiscal year.

  • Domino’s Pizza (NYSE:DPZ) stock rose 1.3% after Cowen upgrades the fast-food retailer to ‘outperform’, saying it “is implementing a successful long-term playbook to help extend the success the off-premise (delivery and carry-out) and digitally oriented business is seeing amid Covid-19.”

  • eBay (NASDAQ:EBAY) stock will be in focus after founder Pierre Omidyar stepped down from the online marketplace operator’s board of directors as part of an overhaul. Elliott Management partner Jesse Cohn is also leaving the eBay board.

  • Satsuma Pharmaceuticals (NASDAQ:STSA) stock fell 7.3% after being downgraded by both Credit Suisse (SIX:CSGN) and Mizuho.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.